Sigma-Aldrich (FRA:SIQ) Forward PE Ratio : 29.50 (As of May. 17, 2024)

View and export this data going back to . Start your Free Trial

What is Sigma-Aldrich Forward PE Ratio?

Sigma-Aldrich's Forward PE Ratio for today is 29.50.

Sigma-Aldrich's PE Ratio without NRI for today is 36.67.

Sigma-Aldrich's PE Ratio for today is 36.67.

Sigma-Aldrich Forward PE Ratio Historical Data

The historical data trend for Sigma-Aldrich's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sigma-Aldrich Forward PE Ratio Chart

Sigma-Aldrich Annual Data

Trend

Forward PE Ratio

Sigma-Aldrich Quarterly Data

Forward PE Ratio

Competitive Comparison of Sigma-Aldrich's Forward PE Ratio

For the Specialty Chemicals subindustry, Sigma-Aldrich's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sigma-Aldrich's Forward PE Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Sigma-Aldrich's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Sigma-Aldrich's Forward PE Ratio falls into.

Sigma-Aldrich Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Sigma-Aldrich (FRA:SIQ) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

Sigma-Aldrich Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Sigma-Aldrich's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Sigma-Aldrich (FRA:SIQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Sigma-Aldrich Corp (FRA:SIQ) » Definitions » Forward PE Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.sigma-aldrich.com

Sigma-Aldrich Corp was incorporated under the laws of the State of Delaware in May 1975. The Company is a life science and a technology company that helps in enhancing human health and safety. The Company manufactures and distributes chemicals, biochemicals and other essential products and equipment products to its customers in research and applied labs as well as in industrial and commercial markets. The Company operates in three units including Research, Applied and SAFC Commercial. The Research unit products and services includes chemicals, reagents and kits, enabling the scientists to discover and develop new drugs and materials; Applied unit products and services includes high quality components and kits, chemical reagents, critical raw materials and certified reference standards, providing customized solutions to and constitute critical components and materials for diagnostic companies, testing laboratories and industrial companies; SAFC Commercial unit's products and services are used by its customers to develop and manufacture pharma, biopharma and electronics products. Its customers include pharmaceutical companies, universities, commercial laboratories, industrial companies, biotechnology companies, non-profit organizations, governmental institutions, diagnostic, chemical and electronics companies and hospitals. The Company's trademarks are the brand names; Sigma-Aldrich, Sigma, Aldrich, Fluka, Riedel-de HaÃ«n, Supelco, SAFC, SAFC Biosciences, SAFC Hitech, Genosys, Proligo, Pharmorphix, Cerilliant, Vetec, BioReliance and Cell Marque. The Company is subject to extensive regulation by federal, state and local governments and similar international agencies relating to the manufacture, sale and distribution of its products.

Sigma-Aldrich (FRA:SIQ) Headlines

No Headlines